Intelligent Bio Solutions Expands Global Reach with Multilingual Digital Strategy
TL;DR
INBS gains competitive edge with multilingual websites for key markets.
INBS launches Arabic, Italian, and Spanish websites to expand globally.
INBS's non-invasive drug testing improves workplace safety worldwide.
INBS's fingerprint sweat-based screening system offers innovative drug testing solutions.
Found this article helpful?
Share it with your network and spread the knowledge!
Intelligent Bio Solutions (NASDAQ: INBS) is strategically expanding its digital presence by introducing localized websites in Arabic, Italian, and Spanish languages. This multilingual approach aims to facilitate market penetration in Latin America, the Middle East, and Southern Europe, regions representing over 1.4 billion potential customers.
The company's digital rollout supports its broader commercial strategy, targeting growing international demand for workplace safety and compliance solutions. Currently, INBS's flagship fingerprint sweat-based drug screening system is utilized by more than 450 clients across 24 countries, demonstrating significant market traction.
By removing language barriers, the company seeks to streamline digital engagement and accelerate its sales pipeline in these high-potential regions. The initiative positions INBS to capitalize on increasing global interest in non-invasive workplace drug testing technologies.
With plans for a U.S. market launch in 2025 and ongoing development of additional biosensor applications, the multilingual website strategy represents a critical step in INBS's international expansion strategy. The approach signals the company's commitment to accessibility and global market penetration in the medical technology sector.
Curated from InvestorBrandNetwork (IBN)
